Published 1 year ago

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Summary by Ground News

Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.

0 Articles

All

Left

Center

Right

The Hindu

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Vietnam’s Center for Research and Production of Vaccines and Biologicals, also known as Polyvac, will be supplying the measles vaccine component, while the rubella vaccine component will be produced by IIL to manufacture a combined MR vaccine.

1 year ago·India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.